Medical treatment of autism spectrum disorder in children: Current evidence, controversies, and clinical challenges
Yousif M Elbeltagi, Ahmed Osama Abd Rab El Rasool, Ahmed Mohammed Elkashlan, Mohammed Al-Beltagi · 2026
Read Medical treatment of autism spectrum disorder in children: Current evidence, controversies, and clinical challenges by Yousif M Elbeltagi, Ahmed Osama Abd Rab El Rasool, Ahmed Mohammed Elkashlan, Mohammed Al-Beltagi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13217184.txt.
Description
Elbeltagi and colleagues review drug treatment for autism spectrum disorder in children. Autism brings varied challenges, and no approved drug treats its core social and communication differences. Medicines are therefore aimed at problems that ride along with it, such as aggression, irritability, gut trouble, and sleep disturbance.
The review weighs five major drug classes for benefit and harm. It also judges early work on biomarker-guided care, where a child's biology might steer drug choice. Controversies run through the field, from weak trial evidence to long-term safety worries. The authors call for careful, individual prescribing, and for trials that match treatments to the children most likely to gain.
Catalog record
| CREATOR | Yousif M Elbeltagi, Ahmed Osama Abd Rab El Rasool, Ahmed Mohammed Elkashlan, Mohammed Al-Beltagi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 175 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |